Cargando…

Pulmonary Arterial Hypertension in Intensive Care Unit

For the intensive care unit (ICU) physician, the diagnosis of pulmonary arterial hypertension (PAH) is difficult as it can easily be confounded with other forms of pulmonary hypertension (PH). The key issue is that PAH is a form of PH. On the opposite, PH does not automatically imply PAH. Pulmonary...

Descripción completa

Detalles Bibliográficos
Autores principales: Muller, Laurent, Bengler, Christian, Roger, Claire, Cohendy, Robert, Lefrant, Jean Yves
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7120311/
http://dx.doi.org/10.1007/978-3-319-04576-4_5
_version_ 1783514944967278592
author Muller, Laurent
Bengler, Christian
Roger, Claire
Cohendy, Robert
Lefrant, Jean Yves
author_facet Muller, Laurent
Bengler, Christian
Roger, Claire
Cohendy, Robert
Lefrant, Jean Yves
author_sort Muller, Laurent
collection PubMed
description For the intensive care unit (ICU) physician, the diagnosis of pulmonary arterial hypertension (PAH) is difficult as it can easily be confounded with other forms of pulmonary hypertension (PH). The key issue is that PAH is a form of PH. On the opposite, PH does not automatically imply PAH. Pulmonary arterial hypertension must be differentiated from other causes of PH that are frequently seen in ICU. It was recently emphasized that pulmonary veno-occlusive disease (PVOD) must be differentiated from PH and PAH. The prognosis of PAH was consistently improved in the ten past years by introduction of selective pulmonary vasodilators and management by highly specialized medical teams. In ICU patients, PAH remains a severe disease with a high mortality rate. When PAH is suspected, a systematic diagnosis approach is of particular importance in order to rapidly eliminate left cardiac, thromboembolic and pulmonary causes of PH. Left cardiac disease is the most common cause of PH. Early recognition of PAH allows a rapid introduction of selective pulmonary vasodilators that can improve outcome. Idiopathic PAH is the most frequent cause but it can also be associated with scleroderma, HIV infection, anorexigen toxicity, thyroid disease, cirrhosis. Pulmonary vasodilators should be only a part of a general management including treatment of triggering factors, optimization of fluid balance, decrease of RV afterload by using pulmonary vasodilators while maintaining cardiac output and mean arterial pressure. The early contact of PH referral center or specialized physician is of particular importance.
format Online
Article
Text
id pubmed-7120311
institution National Center for Biotechnology Information
language English
publishDate 2014
record_format MEDLINE/PubMed
spelling pubmed-71203112020-04-06 Pulmonary Arterial Hypertension in Intensive Care Unit Muller, Laurent Bengler, Christian Roger, Claire Cohendy, Robert Lefrant, Jean Yves Uncommon Diseases in the ICU Article For the intensive care unit (ICU) physician, the diagnosis of pulmonary arterial hypertension (PAH) is difficult as it can easily be confounded with other forms of pulmonary hypertension (PH). The key issue is that PAH is a form of PH. On the opposite, PH does not automatically imply PAH. Pulmonary arterial hypertension must be differentiated from other causes of PH that are frequently seen in ICU. It was recently emphasized that pulmonary veno-occlusive disease (PVOD) must be differentiated from PH and PAH. The prognosis of PAH was consistently improved in the ten past years by introduction of selective pulmonary vasodilators and management by highly specialized medical teams. In ICU patients, PAH remains a severe disease with a high mortality rate. When PAH is suspected, a systematic diagnosis approach is of particular importance in order to rapidly eliminate left cardiac, thromboembolic and pulmonary causes of PH. Left cardiac disease is the most common cause of PH. Early recognition of PAH allows a rapid introduction of selective pulmonary vasodilators that can improve outcome. Idiopathic PAH is the most frequent cause but it can also be associated with scleroderma, HIV infection, anorexigen toxicity, thyroid disease, cirrhosis. Pulmonary vasodilators should be only a part of a general management including treatment of triggering factors, optimization of fluid balance, decrease of RV afterload by using pulmonary vasodilators while maintaining cardiac output and mean arterial pressure. The early contact of PH referral center or specialized physician is of particular importance. 2014-01-17 /pmc/articles/PMC7120311/ http://dx.doi.org/10.1007/978-3-319-04576-4_5 Text en © Springer International Publishing Switzerland 2014 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Article
Muller, Laurent
Bengler, Christian
Roger, Claire
Cohendy, Robert
Lefrant, Jean Yves
Pulmonary Arterial Hypertension in Intensive Care Unit
title Pulmonary Arterial Hypertension in Intensive Care Unit
title_full Pulmonary Arterial Hypertension in Intensive Care Unit
title_fullStr Pulmonary Arterial Hypertension in Intensive Care Unit
title_full_unstemmed Pulmonary Arterial Hypertension in Intensive Care Unit
title_short Pulmonary Arterial Hypertension in Intensive Care Unit
title_sort pulmonary arterial hypertension in intensive care unit
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7120311/
http://dx.doi.org/10.1007/978-3-319-04576-4_5
work_keys_str_mv AT mullerlaurent pulmonaryarterialhypertensioninintensivecareunit
AT benglerchristian pulmonaryarterialhypertensioninintensivecareunit
AT rogerclaire pulmonaryarterialhypertensioninintensivecareunit
AT cohendyrobert pulmonaryarterialhypertensioninintensivecareunit
AT lefrantjeanyves pulmonaryarterialhypertensioninintensivecareunit